Stay updated on Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.

Latest updates to the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision tag was updated to v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0. This update does not change core page content, study data, or user-facing features.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary display has been added to the page. Text updates include capitalization changes for QC-related labels, an added FEAR Act data note, and a new site revision tag (v3.4.0) replacing the old version (v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a revision label update from v3.3.3 to v3.3.4, with no impact on study details or user-facing content. This is a minor technical update to the page version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA new Locations section appears listing sites in Nevada, New Jersey, and South Carolina. The older state-specific location subsections were removed, and the footer’s HHS Vulnerability Disclosure link was deleted.SummaryDifference0.3%

- Check91 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Loncastuximab Tesirine vs Idelalisib in Follicular Lymphoma Clinical Trial page.